Slideshow
Author(s):
Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
Parkinson Agent Prasinezumab Misses Primary End Point But Shows Positive Effects in Other Outcomes
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Tavapadon Meets Primary and Secondary End Points in Phase 3 TEMPO-2 Trial for Early Parkinson Disease
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
APOE4 Allele Carriers and Parkinson Disease Named Among Highest Risk Factors for Epilepsy in Patients With Dementia
System Integration: How AI Is Weaving Itself into Neurology